CD276 and desmoplastic small round cell tumor: Clinical trials with B7-H3 blocking antibody 8H9, also in combination with PD-1 blockade, are currently ongoing for treating patients with recurrent metastatic neuroblastoma and desmoplastic small round cell tumors in the peritoneum [15].